UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Looking for quick cash? Discover the best methods to boost your income fast and effectively. Start making money today!
22,494 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
In 1973, Warren Buffett bought distressed Berkshire stock for $40 a share. The move epitomized his patient, crisis-dr...
A small BTC sale by Strategy is not a capitulation. The firm says the move funds preferred stock distributions while ...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
A hypothetical White House event paid UFC winners with a stablecoin issued by a family-backed venture, igniting a deb...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
Electric-vehicle names rise as a broad tech rebound fuels gains; Tesla jumps 8%, Rivian and Lucid climb about 7% in a...
ARK Invest doubled down on SpaceX after a market pullback, funding the move by trimming Alibaba. The trade underscore...
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
A wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
Quantum Computing Inc. (QUBT) is due to report Q4 2025 results after the market closes, with traders eyeing a narrow ...
Apple posted a record iPhone revenue quarter and strong customer satisfaction, yet the market remains divided on how ...